The University of Southampton
University of Southampton Institutional Repository

Bridging the gap: Maternal immunisation as a means to reduce neonatal deaths from infectious diseases

Bridging the gap: Maternal immunisation as a means to reduce neonatal deaths from infectious diseases
Bridging the gap: Maternal immunisation as a means to reduce neonatal deaths from infectious diseases
Although significant progress towards Millennium Goals 4 and 5 has been recorded, neonatal mortality remains a global challenge. There were an estimated 3·3 million neonatal deaths worldwide in 2009, accounting for a significant proportion of under-5-year mortality. Progress in this age group is now most urgently required.Citation1 Infectious diseases are the major cause of neonatal deaths and some can be prevented by vaccination, which is accepted as one of the most successful and cost-effective health interventions. However, to achieve full protection against infections requires multiple doses of vaccines given over several months in the first year of life.
During this particularly vulnerable period of early infancy, newborns remain partially protected through transfer of immunoglobulins from the mother, which carry specific antibodies against infections or vaccine antigens that the mother had previously encountered. However, maternal levels of such specific immunoglobulin (IgG) are frequently sub-optimal.Citation2 Maternal immunisation represents a strategy that could be employed to ‘bridge the gap’ in protection: the aim is to enhance the antibody levels against a particular infectious disease by giving the vaccine to the pregnant woman, who will then transmit a protective level of antibody to her infant in utero and through breastmilk after birth. Multiple factors can affect the transfer of IgG across the placenta, including maternal IgG concentration, the IgG subtype, gestational age and maternal co-infections, such as HIV.Citation3 These factors, among others, also determine the level of immunity that an infant can obtain from a maternal vaccine
2047-7724
137-138
Lindsey, Ben
085fb6e5-3d41-4443-a8a5-4b710f68e84c
Jones, Christine
48229079-8b58-4dcb-8374-d9481fe7b426
Kampmann, Beate
4490f5e3-318c-4074-bf69-4a23bd5ec100
Lindsey, Ben
085fb6e5-3d41-4443-a8a5-4b710f68e84c
Jones, Christine
48229079-8b58-4dcb-8374-d9481fe7b426
Kampmann, Beate
4490f5e3-318c-4074-bf69-4a23bd5ec100

Lindsey, Ben, Jones, Christine and Kampmann, Beate (2012) Bridging the gap: Maternal immunisation as a means to reduce neonatal deaths from infectious diseases. Pathogens and Global Health, 106 (3), 137-138. (doi:10.1179/204777312X13462106637684).

Record type: Article

Abstract

Although significant progress towards Millennium Goals 4 and 5 has been recorded, neonatal mortality remains a global challenge. There were an estimated 3·3 million neonatal deaths worldwide in 2009, accounting for a significant proportion of under-5-year mortality. Progress in this age group is now most urgently required.Citation1 Infectious diseases are the major cause of neonatal deaths and some can be prevented by vaccination, which is accepted as one of the most successful and cost-effective health interventions. However, to achieve full protection against infections requires multiple doses of vaccines given over several months in the first year of life.
During this particularly vulnerable period of early infancy, newborns remain partially protected through transfer of immunoglobulins from the mother, which carry specific antibodies against infections or vaccine antigens that the mother had previously encountered. However, maternal levels of such specific immunoglobulin (IgG) are frequently sub-optimal.Citation2 Maternal immunisation represents a strategy that could be employed to ‘bridge the gap’ in protection: the aim is to enhance the antibody levels against a particular infectious disease by giving the vaccine to the pregnant woman, who will then transmit a protective level of antibody to her infant in utero and through breastmilk after birth. Multiple factors can affect the transfer of IgG across the placenta, including maternal IgG concentration, the IgG subtype, gestational age and maternal co-infections, such as HIV.Citation3 These factors, among others, also determine the level of immunity that an infant can obtain from a maternal vaccine

This record has no associated files available for download.

More information

Published date: 12 November 2012

Identifiers

Local EPrints ID: 474902
URI: http://eprints.soton.ac.uk/id/eprint/474902
ISSN: 2047-7724
PURE UUID: da9ac925-dde4-4a46-b05d-c6a32e7caa03
ORCID for Christine Jones: ORCID iD orcid.org/0000-0003-1523-2368

Catalogue record

Date deposited: 06 Mar 2023 17:58
Last modified: 17 Mar 2024 03:45

Export record

Altmetrics

Contributors

Author: Ben Lindsey
Author: Christine Jones ORCID iD
Author: Beate Kampmann

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×